Merdad Parsey Gilead Sciences, Inc. (GILD) insider trading activity

GILD Quotes by TradingView

Merdad Parsey is Chief Medical Officer of GILEAD SCIENCES, INC.. Currently has a direct ownership of 99,599 shares of GILD, which is worth approximately $8.98 Million. The most recent transaction as insider was on Feb 15, 2021, when has been sold 364 shares (Common Stock) at a price of $56.86 per share, resulting in proceeds of $20,697. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.6K
3.34% 3M change
42.02% 12M change
Total Value Held $8.98 Million

Merdad Parsey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2021
BUY
Grant, award, or other acquisition
$20,697 $56.86 p/Share
364 Added 2.88%
12,263 Common Stock
Jan 26 2021
BUY
Grant, award, or other acquisition
-
9,214 Added 43.64%
11,899 Common Stock
Nov 10 2020
SELL
Payment of exercise price or tax liability
$146,458 $60.62 p/Share
2,416 Reduced 47.36%
2,685 Common Stock
Nov 10 2020
BUY
Exercise of conversion of derivative security
-
5,101 Added 50.0%
5,101 Common Stock

Also insider at

SGMT
Sagimet Biosciences Inc.
Director
MP

Merdad Parsey

Chief Medical Officer
Foster City, CA

Track Institutional and Insider Activities on GILD

Follow GILEAD SCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GILD shares.

Notify only if

Insider Trading

Get notified when an Gilead Sciences, Inc. insider buys or sells GILD shares.

Notify only if

News

Receive news related to GILEAD SCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GILD